ADVENT On Air

The Multifaceted Patient Burden and Drivers of Disease in Prurigo Nodularis

2026-05-07

In this episode, Dr. Sarina Elmariah and Dr. Brian Kim explore prurigo nodularis (PN), with a focus on severe itch, fibrotic skin lesions, and their impact on patients’ quality of life. They discuss PN epidemiology, common comorbidities, and the challenges of managing multimorbid patients, while breaking down the neuroimmune mechanisms, highlighting the role of type 2 cytokines in itch and lesion development.



ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.



This podcast is intended for healthcare professionals only.




Disclaimer:
This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.

The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program.

The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits.


Speaker disclosures:


Sarina Elmariah, MD, PhD, MPH has the following interests to disclose: Consultant, advisor, or investigator: Bambusa Therapeutics, Celldex, Disc Medicine, Galderma, Incyte, Novartis, Pfizer, Regeneron, Sanofi, ZenZema

Brian Kim, MD, is co-founder of Alys Pharmaceuticals and Neurommune Therapeutics; he has served as a consultant for ABRAX Japan, AbbVie, Amgen, Attovia Therapeutics, Eli Lilly and Company, Evommune, Galderma, Gilead, LEO Pharma, Neurocrine, Novartis, Pfizer, Recens Medical, Regeneron, Sanofi, Septerna, Triveni Bio; he has stock in ABRAX Japan, Alys Pharamaceuticals, Attovia Therapeutics, Locus Biosciences, Neurommune Therapeutics, Recens Medical, and Triveni Bio.




© 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

MAT-GLB-2504334 – 1.0 – 05/2026

MAT-US-2604824 v1.0 - P Expiration Date: 05/4/2028

Número de episodios

28

Último episodio

2026-10-08

¿Donde puedes escuchar?

The latest updates in type 2 inflammatory science, brought to you by leading experts in the field.
The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area.
Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com.
This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanofi and Regeneron, and is intended for healthcare professionals.

©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-GLB-2302644 v2.0 07/2023
MAT-US-2304947 v1.0-P Exp. Date 07/07/2025